Determinants of Developing Diabetes Mellitus and Vascular Complications in Patients with Impaired Fasting Glucose

Overview

Journal Indian J Endocrinol Metab

Specialty Endocrinology

Date 2013 Oct 2

PMID 24083174

Citations 1

Authors

Faranak Sharifi

Yahya Jaberi

Fatemeh Mirzamohammadi

Hamid Mirzamohammadi

Nouraddin Mousavinasab

Affiliations

Soon will be listed here.

Abstract

Aims: To detect the risk factors of diabetes mellitus (DM) and cardiovascular complications in subjects with impaired fasting glucose (IFG).

Materials And Methods: One hundred and twenty three subjects with proved IFG in Zanjan Healthy Heart Study (2002-2003) were recalled and participated in this study (2009-2010). Demographic and laboratoryinformation of the participants were collected.Ischemic heart disease (IHD) was assessed by the exercise tolerance test (ETT). All the subjects with abnormal ETT or documented past history of IHD confirmed by angiographic evaluation. Ophthalmic complications including cataract, glaucoma, and diabetic retinopathy were estimated by an ophthalmologist.

Results: Incidence of DM was 19.5%. All the diabetic and pre-diabetic patients had at least one of the other components of metabolic syndrome. Obesity (P: 0.04, OR: 1.8, 95%CI: 1.2-9) and low physical activity (P < 0.001, OR: 9.6, 95%CI: 3.4-32) were the only independent prognostic risk factors for progression to DM in patients with IFG. Total incidence of IHD was 14.6% and had a strong correlation with sex (P: 0.01, OR: 1.8, 95%CI: 1.2-1.5), age (P < 0.001, OR: 23, 95%CI: 2.1-67) and cigarette smoking (P < 0.001, OR: 36.5, 95%CI: 3.9-337). Non-proliferative diabetic retinopathy was shown in 2 (1.6%) subjects who were all women.

Conclusion: Obesity and low physical activity are the main factors of developing DM and its macrovascular complications in subjects with IFG.

Citing Articles

Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.

Richter B, Hemmingsen B, Metzendorf M, Takwoingi Y Cochrane Database Syst Rev. 2018; 10:CD012661.

PMID: 30371961 PMC: 6516891. DOI: 10.1002/14651858.CD012661.pub2.

References

Tulloch-Reid M, Williams D, Looker H, Hanson R, Knowler W . Do measures of body fat distribution provide information on the risk of type 2 diabetes in addition to measures of general obesity? Comparison of anthropometric predictors of type 2 diabetes in Pima Indians. Diabetes Care. 2003; 26(9):2556-61. DOI: 10.2337/diacare.26.9.2556. View

Skarfors E, Selinus K, Lithell H . Risk factors for developing non-insulin dependent diabetes: a 10 year follow up of men in Uppsala. BMJ. 1991; 303(6805):755-60. PMC: 1670998. DOI: 10.1136/bmj.303.6805.755. View

Suadicani P, Hein H, von Eyben F, Gyntelberg F . Metabolic and lifestyle predictors of ischemic heart disease and all-cause mortality among normal weight, overweight, and obese men: a 16-year follow-up in the Copenhagen Male Study. Metab Syndr Relat Disord. 2008; 7(2):97-104. DOI: 10.1089/met.2008.0041. View

Ford E, Zhao G, Li C . Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence. J Am Coll Cardiol. 2010; 55(13):1310-7. DOI: 10.1016/j.jacc.2009.10.060. View

Iribarren C, Go A, Husson G, Sidney S, Fair J, Quertermous T . Metabolic syndrome and early-onset coronary artery disease: is the whole greater than its parts?. J Am Coll Cardiol. 2006; 48(9):1800-7. DOI: 10.1016/j.jacc.2006.03.070. View

Weiss R . Impaired glucose tolerance and risk factors for progression to type 2 diabetes in youth. Pediatr Diabetes. 2007; 8 Suppl 9:70-5. DOI: 10.1111/j.1399-5448.2007.00336.x. View

Huang H, Farmer K, Windscheffel J, Yost K, Power M, Wright D . Exercise increases insulin content and basal secretion in pancreatic islets in type 1 diabetic mice. Exp Diabetes Res. 2011; 2011:481427. PMC: 3170797. DOI: 10.1155/2011/481427. View

Tuomilehto J, Lindstrom J, Eriksson J, Valle T, Hamalainen H, Ilanne-Parikka P . Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001; 344(18):1343-50. DOI: 10.1056/NEJM200105033441801. View

Waxman A . WHO global strategy on diet, physical activity and health. Food Nutr Bull. 2004; 25(3):292-302. DOI: 10.1177/156482650402500310. View

10.

Liu J, Grundy S, Wang W, Smith Jr S, Vega G, Wu Z . Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome. Am Heart J. 2007; 153(4):552-8. DOI: 10.1016/j.ahj.2007.01.003. View

11.

Rajala U, Laakso M, Qiao Q, Keinanen-Kiukaanniemi S . Prevalence of retinopathy in people with diabetes, impaired glucose tolerance, and normal glucose tolerance. Diabetes Care. 1998; 21(10):1664-9. DOI: 10.2337/diacare.21.10.1664. View

12.

Shiota M, Printz R . Diabetes in Zucker diabetic fatty rat. Methods Mol Biol. 2012; 933:103-23. DOI: 10.1007/978-1-62703-068-7_8. View

13.

Bjornholt J, Erikssen G, Liestol K, JERVELL J, Thaulow E, Erikssen J . Type 2 diabetes and maternal family history: an impact beyond slow glucose removal rate and fasting hyperglycemia in low-risk individuals? Results from 22.5 years of follow-up of healthy nondiabetic men. Diabetes Care. 2000; 23(9):1255-9. DOI: 10.2337/diacare.23.9.1255. View

14.

Muhlestein J, Anderson J, Horne B, Lavasani F, Allen Maycock C, Bair T . Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention. Am Heart J. 2003; 146(2):351-8. DOI: 10.1016/S0002-8703(03)00235-7. View

15.

Uzunlulu M, Oguz A . Is metabolic syndrome a condition independent of prediabetes and type 2 diabetes mellitus? A report from Turkey. Endocr J. 2007; 54(5):745-50. DOI: 10.1507/endocrj.k07-036. View

16.

Tyrberg M, Melander A, Lovestam-Adrian M, Lindblad U . Retinopathy in subjects with impaired fasting glucose: the NANSY-Eye baseline report. Diabetes Obes Metab. 2007; 10(8):646-51. DOI: 10.1111/j.1463-1326.2007.00759.x. View

17.

Wannamethee G, Shaper A, Macfarlane P, Walker M . Risk factors for sudden cardiac death in middle-aged British men. Circulation. 1995; 91(6):1749-56. DOI: 10.1161/01.cir.91.6.1749. View

18.

Faulhaber-Walter R, Jou W, Mizel D, Li L, Zhang J, Kim S . Impaired glucose tolerance in the absence of adenosine A1 receptor signaling. Diabetes. 2011; 60(10):2578-87. PMC: 3178298. DOI: 10.2337/db11-0058. View

19.

de Vegt F, Dekker J, Jager A, Hienkens E, Kostense P, Stehouwer C . Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. JAMA. 2001; 285(16):2109-13. DOI: 10.1001/jama.285.16.2109. View

20.

Ohlson L, Larsson B, Svardsudd K, Welin L, Eriksson H, Wilhelmsen L . The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes. 1985; 34(10):1055-8. DOI: 10.2337/diab.34.10.1055. View